RxDoctor Payments Data

Amal Abdul Hussein

Family Medicine · Southgate, MINPI 1083814420

Payments from drug & device makers

$1,350in general payments, 2019–2025

Across 80 payments — averaging $16.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$350
  • AbbVie$238
  • AstraZeneca$146
  • GSK$108
  • Novo Nordisk$108
  • Lilly USA, LLC$100
  • plus $301 from 9 others

What the payments were for

  • Food & beverage$1,350100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,350 in reported general payments places this provider in the 75th percentile of 3,945 family medicine providers in Michigan.

See all family medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$64,717
Medicare patients
165
Services billed
1,297

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban143$186,649
OzempicSemaglutide87$149,995
JanuviaSitagliptin Phosphate70$95,758
XareltoRivaroxaban77$84,134
TrulicityDulaglutide43$77,206
JardianceEmpagliflozin48$74,708
Trelegy ElliptaFluticasone/Umeclidin/Vilanter47$44,870
FarxigaDapagliflozin Propanediol24$37,457
MounjaroTirzepatide16$32,452
Spiriva RespimatTiotropium Bromide40$31,787
Breo ElliptaFluticasone/Vilanterol44$22,494
LinzessLinaclotide32$21,911
EntrestoSacubitril/Valsartan19$21,458
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr28$20,036
TrintellixVortioxetine Hydrobromide22$14,040

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$350$186,649143 claims
Novo NordiskOzempic$108$149,99587 claims
Lilly USA, LLCTrulicity, Mounjaro$100$109,65859 claims
Boehringer IngelheimJardiance, Spiriva Respimat$32$106,49688 claims
GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta$108$87,400119 claims
Johnson & JohnsonXarelto$48$84,13477 claims
AstraZenecaFarxiga, Symbicort$146$44,71438 claims
AbbVieLinzess$238$21,91132 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,945 family medicine providers in Michigan.

Other family medicine in Southgate

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →